Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 140 posts found.

cells

How ‘deep reading’ of the scientific literature will benefit pharma

September 3, 2015
Research and Development Big Data, Cancer, Data Mining, R&D, literature search, oncology

The US Defense Advanced Research Projects Agency (DARPA)’s $45 million ‘Big Mechanism’ initiative has an ambitious aim.It promises to “leapfrog …

Feature
BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015
Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …

News
AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015
Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …

News
Antibiotic resistance

Rising to meet the infectious disease challenge

July 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …

Feature
The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015
Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

News
Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015
Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

News

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

News
Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015
Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …

Feature
Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

News
BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

News
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

News
Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

News
george_osborne_budget_day_2014

BIA welcomes budget statement

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme

An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023